Diabetes Care, Vol 23, Issue 7 1000-1005, Copyright © 2000 by American Diabetes Association

ARTICLES

Effect of pinitol treatment on insulin action in subjects with insulin resistance

A Davis, M Christiansen, JF Horowitz, S Klein, MK Hellerstein and RE Ostlund
Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri 63110, USA. davis_a@kids.wustl.edu

OBJECTIVE: Endogenous low-molecular-weight glycans containing pinitol (3-O-methyl-D-chiro-inositol) and D-chiro-inositol are thought to mediate certain actions of insulin. We tested the hypothesis that oral administration of soybean-derived pinitol would improve insulin sensitivity in obese subjects (BMI = 36.6 kg/m2) with diet-treated type 2 diabetes or glucose intolerance (HbA1c = 6.8%). RESEARCH DESIGN AND METHODS: There were 22 subjects randomized to receive either pinitol 20 mg x kg(-1) x day(-1) (n = 12) or placebo (n = 10) in a 28-day double-blinded trial. RESULTS: No toxicity due to the pinitol was observed during the study The sensitivity of glucose and lipid metabolism to insulin were assessed by measurement of whole-body glucose, palmitate, and glycerol kinetics during basal conditions and a hyperinsulinemic-euglycemic clamp. Metabolic measurements were made at baseline and again at the end of the study Final plasma levels of pinitol were 48-fold (1.06 +/- 0.15 vs. 0.02 +/- 0.01 micromol/l, P < 0.0001) and D-chiro-inositol levels 14-fold (0.56 +/- 0.08 vs. 0.04 +/- 0.02 micromol/l, P < 0.0001) greater in the pinitol group compared with placebo. CONCLUSIONS: Four weeks of pinitol treatment did not alter baseline glucose production, insulin-mediated glucose disposal, or rates of appearance of free fatty acids and glycerol in plasma. We conclude that plasma levels of both pinitol and D-chiro-inositol are very responsive to pinitol ingestion, but insulin sensitivity does not increase after pinitol treatment in individuals with obesity and mild type 2 diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. Sethi, K. S. Ahn, B. Sung, and B. B. Aggarwal Pinitol targets nuclear factor-{kappa}B activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis Mol. Cancer Ther., June 1, 2008; 7(6): 1604 - 1614. [Abstract] [Full Text] [PDF]

				W. W. Campbell, M. D. Haub, J. D. Fluckey, R. E. Ostlund Jr, J. P. Thyfault, H. Morse-Carrithers, M. W. Hulver, and Z. K. Birge Pinitol Supplementation Does Not Affect Insulin-Mediated Glucose Metabolism and Muscle Insulin Receptor Content and Phosphorylation in Older Humans J. Nutr., November 1, 2004; 134(11): 2998 - 3003. [Abstract] [Full Text] [PDF]